SALT LAKE CITY--(BUSINESS WIRE)--Epitel, a leader in AI for patient-focused brain health technologies, announced today it received U.S. Food and Drug Administration (FDA) 510(k) clearance for REMI ...
Seer Home is an ambulatory EEG system designed to be used at the patient’s home for week-long studies. The Food and Drug Administration (FDA) has granted 510(k) clearance to Seer Home ™ for the ...
Here we present data from two studies, both of which had the purpose of investigating the potential of using electroencephalograms measured from the ear (’ear-EEG’) for sleep monitoring in a home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results